Patient info Open main menu

Rupatadine 10 mg Tablets – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) Details

Medicine strength:
10 mg
Other strengths and forms:
Contains active substance:
ATC code:

Patient leaflet - Rupatadine 10 mg tablets

What Rupatadine is and what it is used for

Rupatadine is an antihistamine.

Rupatadine relieves the symptoms of allergic rhinitis such as sneezing, runny nose, itching in the eyes and nose.

Rupatadine is also used to relieve the symptoms associated with urticaria (an allergic skin rash) such as itching and hives (localised skin redness and swelling).

What you need to know before you take Rupatadine

Do not take Rupatadine

* If you are allergic to rupatadine or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Talk to your doctor or pharmacist before taking Rupatadine. If you suffer from kidney or liver insufficiency, ask your doctor for advice. The use of Rupatadine 10mg tablets is at present not recommended in patients with impaired kidney or liver functions.

If you have low blood levels of potassium and/or if you have a certain abnormal pattern to your heartbeat (known prolongation of the QT interval on the ECG) which can occur in some forms of heart disease, ask your doctor for advice.

If you are older than 65, ask your doctor or your pharmacist.

Children

This medicine is not for use in children under 12 years of age.

Other medicines and Rupatadine

Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines.

If you are taking Rupatadine do not take medicines containing ketoconazole (drug for fungal infections) or erythromycin (drug for bacterial infections).

If you are taking central nervous system depressant medicines, statin medicines (medicines used to treat high cholesterol levels) or midazolam (drug used for sedation of short duration), ask your doctor for advice before taking Rupatadine.

Rupatadine with food, drink and alcohol

Rupatadine should not be taken in combination with grapefruit juice, as this may increase the level of Rupatadine in your body. Rupatadine, at the recommended dose (10mg), does not increase the drowsiness produced by alcohol.

Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before takingthis medicine.

Driving and using machines

At the recommended dosage, Rupatadine is not expected to influence your ability to drive or use machinery. However, when you first start taking Rupatadine you should take care to see how the treatment affects you before driving orusing machines.

Rupatadine contains lactose

If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.

How to take Rupatadine

Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure. Rupatadine is for adolescents (from 12 years and older) and adults. The usual dose is one tablet (10mg of rupatadine) once daily with or without food. Swallow the tablet with a sufficient quantity of liquid (e.g. one glass of water).

Your doctor will tell you how long your treatment with Rupatadine will last.

If you take more Rupatadine than you should

If you have accidentally taken a high dose of your medicine, talk to your doctor or pharmacist immediately.

If you forget to take Rupatadine

Take your dose as soon as possible and then continue with your tablets at the usual times. Do not take a double dose to make up for forgotten individual doses.

Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Common side effects (may affect up to 1 in 10 people): Sleepiness, headache, dizziness, dry mouth, sensation of weakness and fatigue.

Uncommon side effects (may affect up to 1 in 100 people): Increased appetite, irritability, difficulty concentrating, nosebleed, nasal dryness, sore throat, cough, dry throat, rhinitis, nausea, abdominal pain, diarrhoea, indigestion, vomiting, constipation, rash, back pain, joint pain, muscle pain, thirst, general discomfort, fever, abnormal liver function test and increased weight.

Rare side effects (may affect up to 1 in 1,000 people):

Palpitations, increased heart rate , and allergic reactions (itching, hives and swelling of the face, lips, tongue or throat).

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme

(website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store). By reporting side effects you can help provide more information on the safety of this medicine.

How to store Rupatadine

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton and blister. The expiry date refers to the last day of that month.

Keep the blisters in the outer carton in order to protect from light.

If your medicine becomes discoloured or shows any other signs of deterioration, ask your pharmacist who will advise you on what to do.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

Ref: 2632/070126/1/F

1

2

3

4

5

6

3

1

2

4

5

Patient Information Leaflet (continued)

Contents of the pack and other information

What Rupatadine contains

* The active substance is rupatadine. Each tablet contains 10 mg of rupatadine (as fumarate).

* The other ingredients are pregelatinised maize starch, microcrystalline cellulose, red iron oxide (E172), yellow iron oxide (E172), lactose monohydrate and magnesium stearate. See section 2 “Rupatadine contains lactose”.

What Rupatadine looks like and contents of the pack Rupatadine tablets are round, light salmon coloured tablets and packed in unit blister doses of 30 tablets.

Manufacturer and Licence Holder

This medicine is manufactured by Noucor Health, S.A., Avda. Cami Reial, 51-57, 08184 Palau-Solita i Plegamansand, Spain and is procured from within the EU and repackaged by the Product Licence Holder: Lexon (UK) Limited, Unit 18, Oxleasow Road, East Moons Moat, Redditch, Worcestershire, B98 0RE.

If you have any questions or are not sure about anything, ask your doctor or pharmacist. They will have additional information about this medicine and will be able to advise you.

PL 15184/2632 Rupatadine 10 mg Tablets

Revision date: 07/01/2026

Blind or partially sighted?

Is this leaflet hard to see or read? Phone Lexon (UK) Limited,

Tel: 01527 505414 to obtain the leaflet in a format suitable for you

POM

Ref: 2632/070126/1/B Rupatadine 10 mg Tablets

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PLPI 15184/2632

Last revision stated in the text: 7 January 2026 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Rupatadine 10 mg tablets

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Rupatadine
Strength 10 mg
Pharmaceutical form Oral tablet
Round, light salmon coloured tablets.
How is it taken Oral
Excipients Pregelatinised maize starch, Microcrystalline cellulose, Red iron oxide (E-172), Yellow iron oxide (E-172), Lactose monohydrate, Magnesium stearate
Pack sizes 30 tablet
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 3 years
Storage Keep the blister in the outer carton in order to protect from light.
Drug group (ATC) Other antihistamines for systemic use
  1. R Respiratory system drugs
    1. R06 Antihistamines for systemic use
      1. R06A Antihistamines for systemic use
        1. R06AX Other antihistamines for systemic use
          1. R06AX28 rupatadine
Marketing authorisation PL 35533/0185 (first authorised 24 October 2007), PLPI 15184/2632
Marketing authorisation holder Aspire Pharma Limited
Codes GTIN 5060209733135 · BNF 03040100

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.1.0 of 12 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.